[1]
P. Badabagni, B. Ramadevi, and J. Sambangi, “Efficacy and safety of adalimumab in treating patients with moderate to severe plaque psoriasis: a retrospective study”, Int J Res Dermatol, vol. 8, no. 1, pp. 8–14, Dec. 2021.